On 11/7/24, REGENXBIO Inc (NASDAQ: RGNX) stock enjoyed a major increase of 18.7%, closing at $11.19. Moreover, this advance was accompanied by exceptionally high trading volume at 320% of normal. The stock has risen 26.6% during the last week but has been extremely weak relative to the market over the last nine months.
Current PriceTarget Research Rating
RGNX is expected to be Value Creation neutral reflecting capital returns that are forecasted to be in line with the cost of capital.
REGENXBIO has a current Value Trend Rating of F (Lowest Rating). With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing highly consistent signals. REGENXBIO has a poor Appreciation Score of 30 and a poor Power Rating of 22, leading to the Lowest Value Trend Rating.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of F. This review will be completed in the next several days.
Be the first to comment